Abstract
Neurodegenerative disorders are characterized by a gradual but irreversible loss of neurological
function. The ability to detect and treat these conditions successfully is crucial for ensuring
the best possible quality of life for people who suffer from them. The development of effective new
methods for managing and treating neurodegenerative illnesses has been made possible by recent
developments in computer technology. In this overview, we take a look at the prospects for applying
computational approaches, such as drug design, AI, ML, and DL, to the treatment of neurodegenerative
diseases. To review the current state of the field, this article discusses the potential of computational
methods for early disease detection, quantifying disease progression, and understanding the
underlying biological mechanisms of neurodegenerative diseases, as well as the challenges associated
with these approaches and potential future directions. Moreover, it delves into the creation of
computational models for the individualization of care for neurodegenerative diseases. The article
concludes with suggestions for future studies and clinical applications, highlighting the advantages
and disadvantages of using computational techniques in the treatment of neurodegenerative diseases.
Graphical Abstract
[6]
Banerjee P. Nutritional interventions for the prevention of neurodegenerative disorders. Antioxidants and Functional Foods for Neurodegenerative Disorders. CRC Press 2021; pp. 425-35.
[19]
Gaff AD. Lou Gehrig: The Lost Memoir. Simon & Schuster 2020.
[65]
Gao Z. Virtual reality exercise as a coping strategy for health and wellness promotion in older adults during the COVID-19 pandemic. MDPI 2020.
[72]
Hoq M, Uddin M, Park S. Vocal Feature Extraction-Based Artificial Intelligent Model for Parkinson’s Disease Detection. Diagnostics 2021; 11: 1076.
[78]
Savva K. Computational drug repurposing for neurodegenerative diseases. In silico Drug Design. Academic Press 2019; pp. 85-118.
[79]
Varshney KK, Gupta JK, Mujwar S. Homocysteine induced neurological dysfunctions: A link to neurodegenerative disorders. Int J Med Res Health Sci 2019; 8(4): 135-46.
[81]
Brogi S. Computational approaches for drug discovery. MDPI 2019; p. 3061.
[85]
Grassmann G. A computational approach to Investigate TDP-43 RNA-recognition motif 2 c-terminal fragments aggregation in amyotrophic lateral sclerosis. Biomolecules 2021; 11: 1905.
[87]
Kamkar H. Application of artificial intelligence in image processing of neurodegenerative disorders: A review study. Interven Pain Med Neuromodul 2022; 2(1): 134223.
[98]
Subasi A. Use of artificial intelligence in Alzheimer’s disease detection. Artificial Intelligence in Precision Health. Academic Press 2020; pp. 257-78.